TY - CHAP M1 - Book, Section TI - Pharmacotherapy of Psychosis and Mania A1 - Meyer, Jonathan M. A2 - Brunton, Laurence L. A2 - Knollmann, Björn C. PY - 2023 T2 - Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 14th Edition AB - AbbreviationsACEI: angiotensin-converting enzyme inhibitorARB: angiotensin receptor blockerCOX-2: cyclooxygenase 2CV: cardiovascularDA: dopamineDRP: dementia-related psychosisECG: electrocardiogramECT: electroconvulsive therapyeGFR: estimated glomerular filtration rateENaC: epithelial Na+ channelEPS: extrapyramidal symptomFGA: first-generation antipsychoticGFR: glomerular filtration rateGI: gastrointestinalGPCR: G protein-coupled receptorGSK: glycogen synthase kinase5HT: serotoninIkr: inwardly rectifying K+ channelsLAI: long-acting injectableLi+: lithiumLSD: lysergic acid diethylamideMCM: major congenital malformationsNDI: nephrogenic diabetes insipidusNMDA:N-methyl-D-aspartateNMS: neuroleptic malignant syndromeODT: oral dissolving tabletPDP: Parkinson’s disease psychosisPgp: P-glycoproteinPI: phosphatidylinositolPK_: protein kinase _, as in PKA, PKB, PKCPP2A: protein phosphatase 2ASCD: sudden cardiac deathSGA: second-generation antipsychoticTAAR1: trace amine-associated receptor 1TD: tardive dyskinesiaTSH: thyrotropin (thyroid-stimulating hormone)VMAT2: vesicular monoamine transporter 2VPA: valproic acid SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1193229643 ER -